Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 375 of 660 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 04/30/11
Due: 04/30/12
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 05/31/17
Due: 05/31/18
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 08/31/97
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/10
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: 02/28/06
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 06/30/13
Due: 06/30/14
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 11/30/01
End: 08/31/05
Due: 08/31/06
Phase: N/A
Priority: Normal
Start: 08/31/99
End: -
Due: -
Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients
Phase: N/A
Priority: Normal
Start: 07/31/06
End: 03/31/10
Due: 03/31/11
Phase: N/A
Priority: Normal
Start: 12/31/01
End: 02/29/04
Due: 02/28/05
Phase: N/A
Priority: Normal
Start: 04/08/20
End: 05/08/21
Due: 05/08/22
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 01/31/18
Due: 01/31/19
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 04/30/12
Due: 04/30/13
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 02/28/06
End: 11/30/07
Due: 11/30/08
Phase: N/A
Priority: Normal
Start: 09/30/13
End: 03/31/19
Due: 03/31/20
Phase: N/A
Priority: Normal
Start: 09/30/12
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/20
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 04/06/04
End: 12/31/30
Due: 12/31/31
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -